Franchise GP Ltd grew its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 49.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,970 shares of the semiconductor company's stock after purchasing an additional 7,310 shares during the period. Lam Research makes up about 3.1% of Franchise GP Ltd's holdings, making the stock its 13th biggest position. Franchise GP Ltd's holdings in Lam Research were worth $7,217,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Paladin Partners LLC purchased a new stake in Lam Research during the 2nd quarter worth about $26,000. Dakota Community Bank & Trust NA bought a new position in Lam Research in the 3rd quarter worth about $33,000. Quintet Private Bank Europe S.A. boosted its stake in Lam Research by 100.0% in the 3rd quarter. Quintet Private Bank Europe S.A. now owns 100 shares of the semiconductor company's stock worth $33,000 after purchasing an additional 50 shares during the period. Bravera Wealth bought a new position in Lam Research in the 2nd quarter worth about $46,000. Finally, Cedar Mountain Advisors LLC grew its holdings in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after buying an additional 85 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.
Wall Street Analyst Weigh In
LRCX has been the topic of a number of recent analyst reports. Morgan Stanley reissued an "overweight" rating and issued a $385.00 price target (up from $367.00) on shares of Lam Research in a report on Monday, October 5th. Cantor Fitzgerald set a $500.00 price target on shares of Lam Research and gave the company an "overweight" rating in a research report on Monday, June 29th. UBS Group reduced their price target on shares of Lam Research from $435.00 to $425.00 and set a "buy" rating for the company in a research report on Tuesday, September 1st. HSBC reaffirmed a "hold" rating and issued a $333.00 price target on shares of Lam Research in a report on Monday, July 27th. Finally, Fundamental Research set a $390.00 price objective on Lam Research in a research report on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Lam Research currently has an average rating of "Moderate Buy" and a consensus price target of $364.59.
View Our Latest Report on Lam Research
Insider Buying and Selling
In other Lam Research news, Director Bethany Mayer sold 9,557 shares of Lam Research stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $314.74, for a total transaction of $3,007,970.18. Following the transaction, the director directly owned 20,995 shares of the company's stock, valued at approximately $6,607,966.30. This trade represents a 31.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Ava Harter sold 5,000 shares of the business's stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the sale, the insider owned 42,462 shares of the company's stock, valued at approximately $12,843,056.52. The trade was a 10.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.31% of the stock is owned by company insiders.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Analysts continue to see substantial recovery potential, with Benzinga’s 22-analyst consensus target of $346 implying roughly 26% upside. Separately, Wall Street estimates point to approximately 25.6% potential upside, supported by upward earnings-estimate revisions. Lam Research Stock Hits Longest Losing Streak Ever: Are There Buyers Around?
- Positive Sentiment: Lam Research is integrating NVIDIA’s NanoVDB open-source library into its SEMulator3D platform, aiming to accelerate GPU-based wafer-etch modeling and support more efficient AI-driven chip design and manufacturing. The collaboration reinforces the company’s exposure to AI-factory investment. Lam Research Ties AI Fab Push to Faster SEMulator3D Modeling
- Positive Sentiment: Twenty-four exchange-traded funds added to their Lam Research holdings on October 13, indicating continued institutional demand despite the recent weakness. 24 ETFs Add to Lam Research Holdings
- Neutral Sentiment: Lam Research is scheduled to report results on October 21. Investors are likely looking for updates on semiconductor equipment demand, AI-related spending and forward guidance before reassessing the stock’s outlook. Lam Research Stock Ahead of October 21 Results
- Negative Sentiment: Hotter-than-expected inflation data intensified concerns that elevated borrowing costs could restrain AI infrastructure investment, pressuring Lam Research and other semiconductor-related stocks. Semiconductor Stocks Trade Down on Inflation Concerns
- Negative Sentiment: LRCX is on course for a ninth consecutive decline, its longest losing streak since 1984, reflecting persistent selling pressure and heightened investor caution ahead of earnings. Lam Research Shares Tumble for Seven Consecutive Sessions
Lam Research Trading Down 3.3%
Shares of LRCX opened at $277.46 on Friday. Lam Research Corporation has a 1-year low of $135.50 and a 1-year high of $438.50. The company has a market capitalization of $347.22 billion, a P/E ratio of 48.17, a P/E/G ratio of 1.14 and a beta of 1.85. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The firm's 50 day simple moving average is $309.98 and its 200 day simple moving average is $308.35.
Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business's quarterly revenue was up 30.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts forecast that Lam Research Corporation will post 9.34 earnings per share for the current fiscal year.
Lam Research Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, October 14th. Shareholders of record on Wednesday, September 23rd were paid a $0.33 dividend. This is an increase from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Wednesday, September 23rd. Lam Research's payout ratio is currently 22.92%.
About Lam Research
(
Free Report)
Lam Research Corporation is a semiconductor equipment company that designs, manufactures, and services systems used in the fabrication of integrated circuits and other electronic devices. Its equipment supports key steps in the wafer manufacturing process, helping semiconductor producers create increasingly small and complex features on silicon wafers.
The company's portfolio includes systems for etch, deposition, wafer cleaning, surface preparation, and related manufacturing processes.
Featured Stories
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.